Invitation to monthly digital events and presentations of quarterly reports

Hamlet Biopharma
|
August 22, 2024

Hamlet BioPharma is pleased to announce the continuation of the digital event series this autumn. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during the Q&A sessions that will follow each presentation. Please visit our web page to join the digital events: https://hamletbiopharma.com/series-of-digital-events-2024/

The digital event are scheduled for:

  • September 18th, 2024, 12:00 CET
  • October 23rd, 2024, 12:00 CET
  • December 11th, 2024, 12:00 CET

Additionally, please note the following dates for quarterly reports:

  • August 28th, 2024: Year-End Report (Q4) 2023/2024
  • October 31st, 2024: Annual Report 2023/2024
  • November 15th, 2024: Quarterly Report (Q1) 2024/2025

We would also like to inform you that the Annual General Meeting 2023/2024 is scheduled for November 21st, 2024 to be held in Malmö, Sweden.

 

To receive information from the company, please subscribe at  https://hamletbiopharma.com/subscribe/.

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive newsletters
© 2025
Hamlet BioPharma.